Related Experiment Video
Updated: May 7, 2025

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
Published on: November 2, 2018
Receptor interacting serine/threonine kinase 2 promotes rheumatoid arthritis progression and partially regulates
Yanzheng Wang1, Meiyu Xu2, Xinxin Liu3
1Department of Medical Laboratory, Yantaishan Hospital, Yantai, China.
Objective:
Rheumatoid arthritis (RA) is a disabling systemic autoimmune disease worldwide; however, its molecular pathway remains largely unknown. Thus, this study aimed to explore the effects of receptor-interacting serine/threonine kinase 2 (RIPK2) on RA progression and its underlying mechanism.
Material And Methods:
RIPK2 expression was analyzed using real-time quantitative polymerase chain reaction, immunohistochemical staining, and Western blot (WB) analysis in RA synovial tissues or cells. Cell viability or proliferation was determined using the cell counting kit-8 and 5-ethynyl-2'-deoxyuridine. Cell metastasis was analyzed using the transwell assay and wound healing assay. Flow cytometry was adopted to measure cell apoptosis. The level of inflammation-related factors was measured using the enzyme-linked immunosorbent assay. WB analysis was used to determine the expression level of nuclear factor kappa B (NF-κB) pathway-related genes.
Results:
RIPK2 was highly expressed in RA synovial tissues and cells. Transfection with RIPK2 short hairpin RNA plasmids reduced the gene expression level of RIPK2 in RA fibroblast-like synoviocytes (FLS) cells. Notably, RIPK2 silencing hindered the proliferation, invasion, and migration of tumor cells as well as accelerated the apoptosis of RA-FLS cells. Furthermore, RIPK2 silencing suppressed the RA-FLS cell inflammatory response and NF-κB pathway.
Conclusion:
RIPK2 silencing could retrain the malignant behavior and inflammatory response of RA-FLSs and partially modulate the NF-κB pathway.
Insights
Receptor-interacting serine/threonine kinase 2 (RIPK2) is highly expressed in rheumatoid arthritis (RA). Silencing RIPK2 reduces RA fibroblast-like synoviocyte proliferation and inflammation, suggesting RIPK2 as a therapeutic target.
Area of Science:
- Immunology
- Molecular Biology
- Rheumatology
Background:
- Rheumatoid arthritis (RA) is a debilitating systemic autoimmune disease with largely unknown molecular pathways.
- Receptor-interacting serine/threonine kinase 2 (RIPK2) is implicated in inflammatory processes.
Purpose of the Study:
- To investigate the role of RIPK2 in rheumatoid arthritis (RA) progression.
- To elucidate the underlying molecular mechanisms of RIPK2 in RA pathogenesis.
Main Methods:
- Quantitative PCR, immunohistochemistry, and Western blot were used to analyze RIPK2 expression in RA tissues and cells.
- Cell counting kit-8, 5-ethynyl-2'-deoxyuridine, transwell, and wound healing assays assessed cell proliferation, invasion, and migration.
- Flow cytometry and ELISA measured apoptosis and inflammatory factors, respectively.
- Western blot analyzed the nuclear factor kappa B (NF-κB) pathway.
Main Results:
- RIPK2 was significantly upregulated in RA synovial tissues and fibroblast-like synoviocytes (FLS).
- RIPK2 silencing in RA-FLS cells inhibited proliferation, invasion, and migration, while promoting apoptosis.
- Silencing RIPK2 suppressed inflammatory responses and partially modulated the NF-κB pathway in RA-FLS cells.
Conclusions:
- RIPK2 plays a crucial role in the malignant behavior and inflammatory response of RA-FLS.
- Targeting RIPK2 may offer a potential therapeutic strategy for rheumatoid arthritis by modulating the NF-κB pathway.
Related Concept Videos
The JAK-STAT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
TGF - β Signaling Pathway
MAPK Signaling Cascades
Regulation of the Unfolded Protein Response

